ZINFORO 600 mg, powder for concentrate for infusion 10 bottles
Active ingredients: 4-[2-[[(6R,7R)-2-Carboxy-7-[[(2Z)-(ethoxyimino)[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium acetate hydrate, CEFTAROLINE FOSAMIL
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusion10 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZINFORO 600 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre
- Marketing authorisation holder
- PFIZER IRELAND PHARMACEUTICALS (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65424751CIP72681843CIP133400926818432Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE CEFTAROLINE FOSAMIL MONOHYDRATÉpoudre | 668,4 mg · un flacon | SA |
| CEFTAROLINE FOSAMILpoudre | 600 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.